LHC — Q1 2020 Earnings Presentation
24 slides from LHC's earnings presentation, May 8, 2020
Slide 1: Supplemental Financial Information First Quarter Ended March 31, 2020
Supplemental Financial Information First Quarter Ended March 31, 2020 May 7, 2020
Slide 2: Forward-Looking Statements
Forward - Looking Statements This presentation contains “forward - looking statements” (as defined in the Securities Litigation Reform Act of 1995 ) regarding, among other things, future events or the future financial performance of the Company . Words such as “anticipate,” “expect,” “project,” “int
Slide 3: Table of Contents
Table of Contents 3 Company overview ………………………………………………………………………… .................... … 4 - 5 COVID - 19 Update ……………………………………………………………… .. ……………………… .......... 6 - 9 Consolidated results ……………………………………………………………… ........................ … .. 10 - 11 Adjustments to net income …………………………………………………………
Slide 4: LHC Group Overview
Home Health Hospice HCBS Home Health & Hospice Home Health & HCBS Home Health, Hospice, & HCBS LHC Group Overview 71.7% 11.6% 9.7% 5.8% 1.3% % of Revenue HH Hospice HCBS Facility-based HCI 4 556 home health locations 60% of U.S. population aged 65+ included in service area 112 hospice locations 111
Slide 5: Q1 2020 Highlights
• Net service revenue increased 2.0% for Q1 as compared to Q1 2019 and exceeded the top end of our Q1 guidance range by $3 mill ion even with the COVID - 19 headwind. • Adjusted net income attributable to LHC Group’s common stockholders was $23.4 million, or $0.75 adjusted earnings per diluted sh ar
Slide 6: COVID-19 Response
• Formed a multi - disciplinary internal COVID - 19 task force in early March to lead our response to the pandemic. • Every employee is screened daily based on CDC guidelines, and every patient (regardless of condition) is seen by a clinician with at least face mask and gloves while COVID patients (
Slide 7: Pre-COVID Trends Compared with Current Trends
Pre COVID - 19 Trends Compared with Current Trends 7 Same Store Organic Admission Growth by 2020 Period over Same Period in 2019 Jan. 1 – Feb. 29 Jan. 1 – Mar. 14 Mar. 15 – Mar. 31 Apr. 1 – Apr. 15 Apr. 16 – Apr. 30 Home Health 11.6% 9.8% - 8.8% - 20.1% - 9.7% Hospice 1.9% 2.4% - 8.5% - 11.4% 1.5% F
Slide 8: Weekly Home Health, Hospice and HCBS Trends
Pre COVID - 19 Trends Compared with Current Trends continued 8 Weekly Home Health, Hospice and HCBS Trends COVID - 19 Period Week Ending Feb. 29, 2020 Mar. 7, 2020 Mar. 14, 2020 Mar. 21, 2020 Mar. 28, 2020 Apr. 4, 2020 Apr. 11, 2020 Apr. 18, 2020 Apr. 25, 2020 May 2, 2020 Home Health : Average weekl
Slide 9: CARES Act Policy Implications
CARES Act Policy Implications 9 Near - term financial benefits are substantial Estimated 2020 financial impact $100 Billion Emergency Funding On April 10, 2020, LHC Group, without application, received $87.5 million from the CARES Act provider relief fund as a formulaic calculation applied to LHC Gr
Slide 10: 2020 Adjusted Consolidated Results
2020 Adjusted Consolidated Results Three months ended March 31 Consolidated Total Adjustments Adjusted Consolidated Net service revenue $512,871 $0 $512,871 Cost of service revenue 321,202 (310) 320,892 Gross margin 191,669 191,979 General and administrative expenses 157,866 (4,546) 153,320 Impairme
Slide 11: Consolidated Results – 2020 vs 2019
Consolidated Results – 2020 vs 2019 Adjusted Three months ended March 31, 2020 Adjusted Consolidated % of rev 2019 Adjusted Consolidated % of rev Net service revenue $512,871 $502,585 Cost of service revenue 320,892 62.6% 316,325 62.9% Gross margin 191,979 37.4% 186,260 37.1% General and administrat
Slide 12: Adjustments to Net Income
Adjustments to Net Income ADJUSTMENTS NET OF TAX Q1 2020 Q1 2019 A cquisition and de novo expenses (1) $1,106 $5,268 Closures/relocations/consolidations (2) 343 2,244 COVID - 19 impact: PPE, supplies and wages (3) 2,108 - CARES Act tax benefit (4) (2,210) - Provider moratorium impairment (5) - 4,322
Slide 13: Adjusted Segment Results
Three Months Ended March 31, 2020 Adjusted Segment Results Home health services Adjustments Adjusted Home health services Hospice services Adjustments Adjusted Hospice services HCBS services Adjustments Adjusted HCBS services Net service revenue $367,821 $367,821 $60,531 $60,531 $48,464 $48,464 Cost
Slide 14: Home Health Segment Adjusted Results – 2020 vs 2019
Three months ended March 31, 2020 Adjusted Home Health Services % of rev 2019 Adjusted Home Health Services % of rev Net service revenue $367,821 $363,035 Cost of service revenue 220,192 59.9% 222,720 61.3% Gross margin 147,629 40.1% 140,315 38.7% General and administrative expenses 112,929 30.7% 10
Slide 15: Hospice Segment Adjusted Results – 2020 vs 2019
Three months ended March 31, 2020 Adjusted Hospice Services % of rev 2019 Adjusted Hospice Services % of rev Net service revenue $60,531 $51,736 Cost of service revenue 37,972 62.7% 32,975 63.7% Gross margin 22,559 37.3% 18,761 36.3% General and administrative expenses 16,114 26.6% 13,928 26.9% Oper
Slide 16: HCBS Segment Adjusted Results – 2020 vs 2019
Three months ended March 31, 2020 Adjusted HCBS Services % of rev 2019 Adjusted HCBS Services % of rev Net service revenue $48,464 $51,785 Cost of service revenue 38,453 79.3% 39,661 76.6% Gross margin 10,011 20.7% 12,124 23.4% General and administrative expenses 11,066 22.8% 10,696 20.7% Operating
Slide 17: Facility-Based Services Segment Results – 2020 vs 2019
Facility - Based Services Segment Adjusted Segment Results – 2020 vs 2019 Three months ended March 31, 2020 Adjusted Facility - based Services % of rev 2019 Adjusted Facility - based Services % of rev Net service revenue $29,681 $27,701 Cost of service revenue 20,342 68.5% 17,574 63.4% Gross margin
Slide 18: Home Care Innovations Segment Results – 2020 vs 2019
Home Care Innovations Segment Adjusted Segment Results – 2020 vs 2019 Three months ended March 31, 2020 HCI Services % of rev 2019 Adjusted HCI Services % of rev Net service revenue $6,374 $8,328 Cost of service revenue 3,933 61.7% 3,395 40.8% Gross margin 2,441 38.3% 4,933 59.2% General and adminis
Slide 19: Industry-Leading Quality and Patient Satisfaction
Industry - Leading Quality and Patient Satisfaction • 85 % of LHC same - store providers have CMS 4 stars or greater for quality 19 Quality April 2020 Jan 2020 LHC Group excluding 2019 acquisitions 4.32 4.36 LHC Group with 2019 acquisitions 4.29 4.32 National average 3.25 3.27 Patient Satisfaction A
Slide 20: Debt and Liquidity Metrics
Debt and Liquidity Metrics Outstanding Debt ( amounts in thousands ) As of Mar. 31, 2020 Total Debt – Balance Sheet $298,071 Less: Cash $8,308 Net Debt $289,763 Net debt to estimated TTM adjusted EBITDA ratio 1.4x Credit Facility ( amounts in thousands ) As of Mar. 31, 2020 Revolver Size $500,000 Le
Slide 21: Focus for 2020
Focus for 2020 Successful execution of our PDGM clinical pathway and efficiency plan Maintain disciplined capital allocation with new joint ventures and other M&A activity Accelerate plans for unlocking untapped potential of co - location strategy Maximize value of Healthcare Innovations business Ma
Slide 22: Non-GAAP Reconciliations
Non - GAAP Reconciliations (Amounts in thousands, unaudited) RECONCILIATION OF ADJUSTED NET INCOME ATTRIBUTABLE TO LHC GROUP Three Months Ended March 31, Three Months Ended March 31, 2020 2019 Net income attributable to LHC Group, Inc.’s common stockholders $22,024 $18,856 Add (net of tax): Acquisit
Slide 23: Adjusted EBITDA Reconciliation
Three Months Ended March 31, Three Months Ended March 31, 2020 2019 Net income $22,024 $18,856 Add: Income tax expense 3,359 3,600 Interest expense, net 2,768 3,052 Depreciation and amortization 5,133 4,202 Adjustment items (*) 4,856 16,404 Adjusted EBITDA $38,140 $46,114 (*) Adjustment items (pre -
Slide 24: LHC Group - It's all about helping people
ct) LHc € JR © W P It’s all about helping people.